Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521771-31-00

Acronym

UMCG-NEOLYNC-001

Enrollment

Registered

2025-08-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026